A Case Report of Microifusion of Drugs Into the Skin (MMP®) with Minoxidil in Chronic Telogen Effluvium

    September 2024 in “ Journal of Skin and Stem Cell
    Adriana de Carvalho Corrêa, Carla Jorge Machado, Sueli Coelho da Silva Carneiro
    This case report examines the use of Microinfusion of drugs into the skin (MMP®) with minoxidil for treating chronic telogen effluvium (CTE) in a 28-year-old female. Over three monthly sessions, MMP® with 0.5% minoxidil was applied to the right scalp, followed by daily 5% minoxidil application. Results showed a modest improvement in hair density, with an increase of 47 hairs in the parieto-vertex region. The treatment was well-tolerated, suggesting that MMP® may enhance minoxidil's effectiveness by activating growth factors and the Wnt signaling pathway. However, further research with larger, controlled trials is necessary to confirm its efficacy.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Research

    1 / 1 results